<Disease><Name>LEBERS HEREDITARY OPTIC NEUROPATHY (LHON)</Name><Synonym>LEBER OPTIC ATROPHY; OPTIC ATROPHY, LEBER TYPE</Synonym><OMIM><Number>535000</Number><URL>http://omim.org/entry/535000</URL></OMIM><Orphanet><Number>104</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=104</URL></Orphanet><Protein><Number>
</Number><URL>http://www.uniprot.org/uniprot/?query=database:(type:mim%20535000)&amp;sort=score</URL></Protein><ExPASy><Number>----</Number><URL>http://enzyme.expasy.org/EC/----</URL></ExPASy><Gene>mtDNA</Gene><ICD>H47.2</ICD><Summary>rare ;mitochondrial inheritance ;mitochondrial DNA point mutations that affect the ND subunits of complex I [Baracca et al. 2005]</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>3369</id><symptom>neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3876</id><symptom>vision loss</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>502</id><name>no specific laboratory findings (P, S, U ,CSF)</name><specimen /><value>normal</value><min>    </min><max>    </max><unit /><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7965</id><title>Mitochondrial transport mediates survival of retinal ganglion cells in affected LHON patients</title><author>Yang TC,</author><journal>Hum Mol Genet</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7966</id><title>Pathophysiology of Conversion to Symptomatic Leber Hereditary Optic Neuropathy and Therapeutic Implications: a Review</title><author>Mejia-Vergara AJ,</author><journal>Curr Neurol Neurosci Rep</journal><year>2020</year><book /><volume>20</volume><number>5</number><pages>11</pages><co_aut>et al.</co_aut></literature><literature><id>7967</id><title>The Evaluation of Optic Nerves Using 7 Tesla Silent Zero Echo Time Imaging in Patients with Lebers Hereditary Optic Neuropathy </title><author>Grochowski C,</author><journal>J Clin Med</journal><year>2020</year><book /><volume>9</volume><number>4</number><pages>E1112</pages><co_aut>et al.</co_aut></literature><literature><id>7968</id><title>Seven-Year Follow-up of Gene Therapy for Lebers Hereditary Optic Neuropathy</title><author>Yuan J,</author><journal>Ophthalmology</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7969</id><title>Clinical Features of Chinese Sporadic Leber Hereditary Optic Neuropathy Caused by Rare Primary mtDNA Mutations</title><author>Cui S,</author><journal>J Neuroophthalmol</journal><year>2020</year><book /><volume>40</volume><number>1</number><pages>30-36</pages><co_aut>et al.</co_aut></literature><literature><id>7970</id><title>Factors associated with rapid improvement in visual acuity in patients with Lebers hereditary optic neuropathy after gene thera</title><author>Liu HL,</author><journal>Acta Ophthalmol</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7971</id><title>Current and Emerging Treatment Modalities for Lebers Hereditary Optic Neuropathy: A Review of the Literature</title><author>Theodorou-Kanakari A,</author><journal>Adv Ther</journal><year>2018</year><book /><volume>35</volume><number>10</number><pages>1510-1518</pages><co_aut>et al.</co_aut></literature><literature><id>4718</id><title>Investigating Lebers hereditary optic neuropathy: Cell models and future perspectives</title><author>Jankauskaite E,</author><journal>Mitochondrion</journal><year>2017</year><book /><volume>32</volume><number>0</number><pages>19-26</pages><co_aut>Bartnik E, Kodron A</co_aut></literature><literature><id>4720</id><title>Mitochondria in neuroinflammation - Multiple sclerosis (MS), leber hereditary optic neuropathy (LHON) and LHON-MS</title><author>Bargiela D,</author><journal>Neurosci Lett</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Chinnery PF</co_aut></literature><literature><id>5593</id><title>Childhood-onset Leber hereditary optic neuropathy</title><author>Majander A,</author><journal>Br J Ophthalmol</journal><year>2017</year><book /><volume>101</volume><number>11</number><pages>1505-1509</pages><co_aut>et al.</co_aut></literature><literature><id>5594</id><title>Mitochondrial genetics and therapeutic overview of Lebers hereditary optic neuropathy</title><author>Manickam AH,</author><journal>Indian J Ophthalmol</journal><year>2017</year><book /><volume>65</volume><number>11</number><pages>1087-1092</pages><co_aut>Michael MJ, Ramasamy S</co_aut></literature><literature><id>5595</id><title>Leber hereditary optic neuropathy: bridging the translational gap</title><author>Jurkute N,</author><journal>Curr Opin Ophthalmol</journal><year>2017</year><book /><volume>28</volume><number>5</number><pages>403-409</pages><co_aut>Yu-Wai-Man P</co_aut></literature><literature><id>4719</id><title>Gene-Based Therapies for Leber Hereditary Optic Neuropathy. Hype or Hope?</title><author>Mackey DA,</author><journal>Asia Pac J Ophthalmol (Phila)</journal><year>2016</year><book /><volume>5</volume><number>4</number><pages>253-254</pages><co_aut>Kearns LS, Hewitt AW</co_aut></literature><literature><id>4721</id><title>Lebers hereditary optic neuropathy is multiorgan not mono-organ</title><author>Finsterer J,</author><journal>Clin Ophthalmol</journal><year>2016</year><book /><volume>10</volume><number>0</number><pages>2187-2190</pages><co_aut>Zarrouk-Mahjoub S</co_aut></literature><literature><id>5596</id><title>Idebenone: A Review in Lebers Hereditary Optic Neuropathy</title><author>Lyseng-Williamson KA</author><journal>Drugs</journal><year>2016</year><book /><volume>76</volume><number>7</number><pages>805-813</pages><co_aut /></literature><literature><id>2709</id><title>Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases</title><author>Debray FG</author><journal>Pediatrics</journal><year>2007</year><book /><volume>119</volume><number>4</number><pages>722-733</pages><co_aut>et al.</co_aut></literature><literature><id>2329</id><title>Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids</title><author>Baracca A</author><journal>Arch Neurol</journal><year>2005</year><book /><volume>62</volume><number>5</number><pages>730-736</pages><co_aut>et al.</co_aut></literature><literature><id>2330</id><title>Bioenergetics shapes cellular death pathways in Lebers hereditary optic neuropathy: a model of mitochondrial neurodegeneration&lt;</title><author>Carelli V</author><journal>Biochim Biophys Acta</journal><year>2004</year><book /><volume>1658</volume><number>0</number><pages>172-179</pages><co_aut>et al.</co_aut></literature><literature><id>476</id><title>Clinical presentations and laboratory invetstigations in respiratory chain deficiency</title><author>Munnich A</author><journal>Eur J Pediatr</journal><year>1996</year><book /><volume>155</volume><number>0</number><pages>262-274</pages><co_aut>et al.</co_aut></literature><literature><id>95</id><title>Oxidative phosphorylation diseases</title><author>Shoffner JM</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>46</number><pages>1535-1609</pages><co_aut>Wallace DC</co_aut></literature><literature><id>492</id><title>Lebers hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome</title><author>Oostra RJ</author><journal>J Med Genet</journal><year>1994</year><book /><volume>31</volume><number>4</number><pages>280-286</pages><co_aut>et al.</co_aut></literature><literature><id>493</id><title>Clinical and genetical manifestations in 34 families with Lebers hereditary optic neuropathy (LHON)</title><author>Meire GM</author><journal>Bull Soc Belge Ophtalmol</journal><year>1994</year><book /><volume>254</volume><number>0</number><pages>137-146</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>